Skin & Aging Article Finds Derma Sciences MEDIHONEY(TM) Helps to Promote Healing Where Antibi...( Researchers Work in-vitro on MRSA VR...)

Researchers Work in-vitro on MRSA, VRE and other multi-resistant organisms

PRINCETON, N.J., May 2 /PRNewswire-FirstCall/ -- Derma Sciences (OTC Bulletin Board: DSCI), a provider of advanced wound care products, today announced that the journal Skin & Aging, in its annual review of top wound care studies, devoted a section to MEDIHONEY(TM) Wound & Burn Dressings with Active Leptospermum Honey. The article, "Spotlighting the Top-10 Research Findings in Wound Care", discusses the research done by Narelle George and Keith Cutting on the product's in-vitro activity against clinical isolates of MRSA, VRE, and other multi-resistant gram-negative organisms including Pseudomonas aeruginosa.

The author of the article, Dr. Robert Kirsner, MD, PhD, and a past president of the Association for the Advancement of Wound Care, states, "A specific honey, the so-called Manuka honey predominantly sourced from the Leptospermum species from New Zealand and Australia, has been found to have other properties that may render it superior to other honeys. Specifically, this honey appears to have superior and broad-spectrum antimicrobial properties." He went on to say that the first Leptospermum honey-based product to enter into the market, MEDIHONEY, is likely to draw significant interest from a public desirous of natural products, and that well-done studies such as the George/Cutting study will help to garner interest by medical professionals.

Derma Sciences CEO Ed Quilty stated, "We are fully aware that, although the benefits of MEDIHONEY have captured the imagination of the public and the medical community alike, it is only through well-designed studies and rigorous clinical evaluations with positive outcomes that widespread adoption and usage of MEDIHONEY will occur. We are glad to see the recognition of the George/Cutting study, and look forward to additional studies on MEDIHONEY being published later this year. Additionally, we continue to receive a stream of po
'/>"/>